Oaktree Acquisition Corp. III Life Sciences (OACCW) Research

Oaktree Acquisition Corp. III Life Sciences presently lacks significant commercial operations. Its primary focus is on completing a business combination, which could take the form of a merger, share exchange, asset acquisition, stock purchase, reorganization, or a similar corporate transaction, with one or more entities. The company aims to identify and acquire businesses operating in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors across North America and Europe. Incorporated in 2024, its base of operations is in Los Angeles, California.

Market snapshot

Symbol
OACCW
Price
$0.82
Day change
0.00%
Market cap
$261.8M
P/E ratio
29.11x
52-week range
0.82-0.99
Sector
Financial Services
Industry
Shell Companies

Peer companies

  • Roman DBDR Acquisition Corp. II (DRDBW)
  • GP-Act III Acquisition Corp. (GPATW)
  • Launch One Acquisition Corp. (LPAAW)
  • Melar Acquisition Corp. I Warrant (MACIW)
  • Plum Acquisition Corp. IV (PLMKW)
  • SIM Acquisition Corp. I (SIMAW)
  • Willow Lane Acquisition Corp. (WLAC)
  • Willow Lane Acquisition Corp. (WLACW)

Recent insider activity

  • Martinez George Arthur — trade (0 shares) on 2025-10-29
  • BERRY DAVID A — trade (0 shares) on 2025-10-17
  • Sweeney Thomas — trade (0 shares) on 2025-06-03
  • Oaktree Acquisition Holdings III LS, LLC — J-Other (231492 shares) on 2024-10-30
  • Oaktree Acquisition Holdings III LS, LLC — C-Conversion (33981 shares) on 2024-10-30

Open Oaktree Acquisition Corp. III Life Sciences (OACCW) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.